Discover and read the best of Twitter Threads about #EidosTherapeutics
Most recents (2)
Analysis: #NASDAQ $EIDX
Case 141 #EidosTherapeutics Inc (Revisited 01)
DISCLAIMER: The analysis is strictly for educational purposes and should not be construed as an invitation to trade.
Thread 👇👇👇
#EIDX 1/3
Case 141 #EidosTherapeutics Inc (Revisited 01)
DISCLAIMER: The analysis is strictly for educational purposes and should not be construed as an invitation to trade.
Thread 👇👇👇
#EIDX 1/3
Chart 1
Weekly Chart: Since peaking at 66.56 price has seen it's longest correction ever finding #support at the weekly #SMA 20. #Resistance at 60.46 is quite formidable and further 68.10. The long term target is 71.30.
EIDX 2/3
Weekly Chart: Since peaking at 66.56 price has seen it's longest correction ever finding #support at the weekly #SMA 20. #Resistance at 60.46 is quite formidable and further 68.10. The long term target is 71.30.
EIDX 2/3
Chart 2
Daily Chart: The #SMA 20 has cut below SMA 50 and we expect price to reach the bottom part of the gap and #trendline support.
The #Strategy is printed on the image.
$EIDX 3/3
Daily Chart: The #SMA 20 has cut below SMA 50 and we expect price to reach the bottom part of the gap and #trendline support.
The #Strategy is printed on the image.
$EIDX 3/3
#Analysis: #NASDAQ: #EIDX
Case 7 #EidosTherapeutics Inc (EIDX)
DISCLAIMER: The analysis is strictly for educational purposes and should not be construed as an invitation to place trades.
Please do your own research!.
Thread 👇👇👇
1/5
Case 7 #EidosTherapeutics Inc (EIDX)
DISCLAIMER: The analysis is strictly for educational purposes and should not be construed as an invitation to place trades.
Please do your own research!.
Thread 👇👇👇
1/5
This stock is recent (June 2018) and data can easily become corrupted and the chart messy. Since the beginning of the year a strong trend began. #Trendlines have appeared reliable. Unfortunately the Fibs aren't effective but still attract price.
Placing it on the Watch List
2/5
Placing it on the Watch List
2/5
Chart 1
Daily Chart: A young stock but price moves haven't been orderly and the rising/falling trendlines look crisp.
3/5
Daily Chart: A young stock but price moves haven't been orderly and the rising/falling trendlines look crisp.
3/5
